$25M Bet On This Consumer Cyclical Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders have recently made significant purchases in penny stocks EVgo, HCW Biologics, and Bioventus. EVgo's director acquired $25 million worth of shares, while HCW Biologics' CFO and Bioventus' Interim CEO bought shares worth $91.08 thousand and $290.99 thousand, respectively.
May 25, 2023 | 11:11 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Bioventus' Interim CEO, Anthony Bihl III, acquired 125,000 shares at an average price of $2.33, spending around $290.99 thousand.
The acquisition of shares by Bioventus' Interim CEO indicates confidence in the company's prospects. This insider activity could have a positive impact on the stock price in the short term, as it signals a bullish sentiment.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
EVgo's director, David Nanus, acquired 5,882,352 shares at an average price of $4.25, totaling around $25 million.
The significant purchase by EVgo's director indicates strong confidence in the company's prospects. This insider activity could positively impact the stock price in the short term as it signals a bullish sentiment.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
HCW Biologics' CFO, Rebecca Byam, acquired 58,486 shares at an average price of $1.56, spending around $91.08 thousand.
The purchase of shares by HCW Biologics' CFO suggests confidence in the company's future performance. This insider activity may have a positive impact on the stock price in the short term, as it indicates a bullish sentiment.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100